HCA Data Explorer

Lung transplantation for patients with severe COVID-19

Updated June 9, 2023

Lung transplantation can potentially be a life-saving treatment for patients with nonresolving COVID-19-associated respiratory failure. Concerns limiting lung transplantation include recurrence of SARS-CoV-2 infection in the allograft, technical challenges imposed by viral-mediated injury to the native lung, and the potential risk for allograft infection by pathogens causing ventilator-associated pneumonia in the native lung. Additionally, the native lung might recover, resulting in long-term outcomes preferable to those of transplant. Here, we report the results of lung transplantation in three patients with nonresolving COVID-19-associated respiratory failure. We performed single-molecule fluorescence in situ hybridization (smFISH) to detect both positive and negative strands of SARS-CoV-2 RNA in explanted lung tissue from the three patients and in additional control lung tissue samples. We conducted extracellular matrix imaging and single-cell RNA sequencing on explanted lung tissue from the three patients who underwent transplantation and on warm postmortem lung biopsies from two patients who had died from COVID-19-associated pneumonia. Lungs from these five patients with prolonged COVID-19 disease were free of SARS-CoV-2 as detected by smFISH, but pathology showed extensive evidence of injury and fibrosis that resembled end-stage pulmonary fibrosis. Using machine learning, we compared single-cell RNA sequencing data from the lungs of patients with late-stage COVID-19 to that from the lungs of patients with pulmonary fibrosis and identified similarities in gene expression across cell lineages. Our findings suggest that some patients with severe COVID-19 develop fibrotic lung disease for which lung transplantation is their only option for survival.

Ankit BharatNorthwestern University, Northwestern Memorial Hospitalabharat@nm.org
Ankit Bharat1
Melissa Querrey1
Nikolay S Markov1
Samuel Kim1
Chitaru Kurihara1
Rafael Garza-Castillon1
Adwaiy Manerikar1
Ali Shilatifard1
Rade Tomic1
Yuliya Politanska1
Hiam Abdala-Valencia1
Anjana V Yeldandi1
Jon W Lomasney1
Alexander V Misharin1
G R Scott Budinger1
1Northwestern University, Northwestern Memorial Hospital
Ida Zucchi

To reference this project, please use the following link:

https://explore.data.humancellatlas.org/projects/5a54c617-0eed-486e-8c1a-8a8041fc1729

Supplementary links are provided by contributors and represent items such as additional data which can’t be hosted here; code that was used to analyze this data; or tools and visualizations associated with this specific dataset.

1.https://github.com/NUPulmonary/2020_Bharat2.https://www.nupulmonary.org/covid-19/3.https://zenodo.org/record/4291961
GEO Series Accessions:INSDC Study Accessions:

Downloaded and exported data is governed by the HCA Data Release Policy and licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). For more information please see our Data Use Agreement.

Analysis Portals

None

Project Label

LungTransplantationCOVID-19

Species

Homo sapiens

Sample Type

specimens

Anatomical Entity

lung

Organ Part

2 organ parts

Selected Cell Types

5 cell types

Disease Status (Specimen)

7 disease statuses

Disease Status (Donor)

10 disease statuses

Development Stage

human adult stage

Library Construction Method

10x 3' v3

Nucleic Acid Source

single cell

Paired End

false

Analysis Protocol

filtered_matrix, merging_matrices, raw_matrix_generation

File Format

4 file formats

Cell Count Estimate

92.0k

Donor Count

5
csv.gz4 file(s)h5.gz44 file(s)h5ad.gz4 file(s)xlsx1 file(s)